The Role of Lymph Node Dissection in Renal Cell Carcinoma: The Pendulum Swings Back

Cancer Journal

Volumn 14, Issue 5, 2008, Pages 308-314

  Margulis, Vitaly ^a   Wood, Christopher G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Lymph node dissection; Oncologic outcomes; Renal cell carcinoma; Staging

Indexed keywords

ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; KIDNEY CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; NEPHRECTOMY; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROPERITONEAL CANCER;

EID: 55349093630     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e31818675eb     Document Type: Article

References (32)

1. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969;101:297-301.
2. Lam JS, Breda A, Belldegrun AS, et al. Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma. J Clin Oncol. 2006;24:5565-5575.
3. Raj GV, Bochner BH. Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard. Semin Oncol. 2007;34:110-121.
4. Studer UE, Scherz S, Scheidegger J, et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol. 1990;144:243-245.
5. Stephenson AJ, Bosl GJ, Motzer RJ, et al. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer. J Clin Oncol. 2007;25:5597-5602.
6. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2007;356:125-134.
7. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007;356:115-124.
8. Hudes G, Carducci M, Tomczak P, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007;356: 2271-2281.
9. Wood CG. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. Clin Cancer Res. 2007; 13:697s-702s.
10. Blute ML, Leibovich BC, Cheville JC, et al. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol. 2004;172:465-469.
11. Canfield SE, Kamat AM, Sanchez-Ortiz RF, et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol. 2006;175:864-869.
12. Pantuck AJ, Zisman A, Dorey F, et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol. 2003;169:2076-2083.
13. Marshall FF, Stewart AK, Menck HR. The National Cancer Data Base: report on kidney cancers. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1997;80: 2167-2174.
14. Blom JH, Schroder FH, Hammond B, et al. Radical nephrectomy with and without lymph node dissection: preliminary results of EORTC protocol 30881. The EORTC genitourinary group. Prog Clin Biol Res. 1992;378:161-167.
15. Minervini A, Lilas L, Morelli G, et al. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery? BJU Int. 2001;88:169-172.
16. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC Cancer Staging Manual. New York: Springer-Verlag, 2002.
17. Terrone C, Cracco C, Porpiglia F, et al. Reassessing the current TNM lymph node staging for renal cell carcinoma. Eur Urol. 2006;49: 324-331.
18. Dimashkieh HH, Lohse CM, Blute ML, et al. Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. J Urol. 2006;176:1978-1982; discussion 1982-1983.
19. Margulis V, Tamboli P, Matin SF, et al. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer. 2008;112: 1480-1488.
20. Peters PC, Brown GL. The role of lymphadenectomy in the management of renal cell carcinoma. Urol Clin North Am. 1980;7:705-709.
21. Herrlinger A, Schrott KM, Schott G, et al. What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma. J Urol. 1991;146:1224-1227.
22. Karakiewicz PI, Trinh QD, Bhojani N, et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol. 2007;51:1616-1624.
23. Vasselli JR, Yang JC, Linehan WM, et al. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. J Urol. 2001;166:68-72.
24. Jacobsohn KM, Wood CG. Adjuvant therapy for renal cell carcinoma. Semin Oncol. 2006;33:576-582.
25. Coll DM, Smith RC. Update on radiological imaging of renal cell carcinoma. BJU Int. 2007;99:1217-1222.
26. Guimaraes AR, Tabatabei S, Dahl D, et al. Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology. 2008;71:708-712.
27. Deleted in proof.
28. Dhar NB, Burkhard FC, Studer UE. Role of lymphadenectomy in clinically organ-confined prostate cancer. World J Urol. 2007;25:39-44.
29. Carver BS, Shayegan B, Eggener S, et al. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol. 2007;25:4365-4369.
30. Terrene C, Guercio S, De Luca S, et al. The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int. 2003; 91:37-40.
31. Joslyn SA, Sirintrapun SJ, Konety BR. Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National surveillance, epidemiology, and end results database. Urology. 2005;65:675-680.
32. Parker AE. Studies on the main posterior lymph channels of the abdomen and their connections with the lymphatics of the genito-urinary system. Am J Anat. 1935:409.